Skip links

Financial Documents & Rendez-Vous

Dear shareholders,
Welcome to your dedicated space, where you can find all the latest information about DMS Group quoted on the Euronext Growth Paris market (ISIN: FR0012202497 - mnemo: ALDMS).

READ THE LATEST INVESTOR PRESENTATION:
– [EN] PDF | DMS Group Overview
– [FR] PDF | Présentation Résultats 2024 et CA T1 2025

LATEST FINANCIAL NEWS

22/04/2025 - 2025 first-quarter revenue: DMS Group records double-digit growth
[FR ONLY]
FINANCIAL
DOCUMENTS
[EN AVAILABLE]
PRESS
RELEASE
[FR ONLY]
GENERAL
MEETINGS
[FR ONLY]
CORPORATE
GOVERNANCE
[FR ONLY]
OTHER REGULATED INFORMATION

Please note: while our press releases are available in English, the rest of our documentation is currently available in French only

IMAGING 2027

Imaging 2027 is DMS Group's strategic plan to establish the company as a key medical imaging player in Europe.

As part of this plan, DMS Group has set ambitious targets for 2027:

Accelerate growth and achieve a revenue of at least €70M

Improve profitability and aim for an EBITDA margin of 14%

FINANCIAL APPOINTMENTS

DATE
DOCUMENT

21 July 2025

Revenue for the 1st half of 2025

29 September 2025

Half-year results 2025

20 October 2025

Revenue for the 3rd quarter of 2025

19 January 2026

Revenue for 2025

CAPITAL ALLOCATION

at 20/12/2024

CapTable
CEO

Samuel SANCERNI
+33 4 66 29 09 07

INVESTOR RELATIONS
PRESS RELATIONS
EMS-logo

For information about European Medical Solutions (formerly DMS Imaging), click here.